申请人:YUNGJIN PHARM. CO., LTD.
公开号:US10766882B2
公开(公告)日:2020-09-08
Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same:
wherein R1 to R6, X1 to X4, and n are the same as defined in claim 1.
本发明公开了一种由式(1)代表的化合物或其药学上可接受的盐、水合物、溶液剂、原药、同系物、对映体或药学上可接受的非对映异构体、制备方法以及药物组合物,其具有治疗或预防代谢综合征的功效:
其中 R1 至 R6、X1 至 X4 和 n 与权利要求 1 中定义的相同。